Extremophilic Cyanobacteria For Novel Drug Development

This volume presents recent developments in the novel drug development and potential of extremophilic cyanobacteria. It discusses how these tiny organism originated, produce oxygen that leads to evolution of life on the earth, how their survival strategies in extreme climatic conditions lead to dive...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autores principales: Mandal, Sikha (Autor), Rath, Jnanendra (Autor)
Autor Corporativo: SpringerLink (Online service)
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Cham : Springer International Publishing : Imprint: Springer, 2015.
Edición:1st ed. 2015.
Colección:SpringerBriefs in Pharmaceutical Science & Drug Development,
Temas:
Pharmaceutical chemistry.
Pharmaceutics.
Acceso en línea:Texto Completo

MARC

LEADER 00000nam a22000005i 4500
001 978-3-319-12009-6
003 DE-He213
005 20220116074458.0
007 cr nn 008mamaa
008 141124s2015 sz | s |||| 0|eng d
020 |a 9783319120096  |9 978-3-319-12009-6 
024 7 |a 10.1007/978-3-319-12009-6  |2 doi 
050 4 |a RS400-431 
072 7 |a PSB  |2 bicssc 
072 7 |a MED072000  |2 bisacsh 
072 7 |a PNB  |2 thema 
082 0 4 |a 615.19  |2 23 
100 1 |a Mandal, Sikha.  |e author.  |4 aut  |4 http://id.loc.gov/vocabulary/relators/aut 
245 1 0 |a Extremophilic Cyanobacteria For Novel Drug Development  |h [electronic resource] /  |c by Sikha Mandal, Jnanendra Rath. 
250 |a 1st ed. 2015. 
264 1 |a Cham :  |b Springer International Publishing :  |b Imprint: Springer,  |c 2015. 
300 |a VII, 92 p. 1 illus.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
490 1 |a SpringerBriefs in Pharmaceutical Science & Drug Development,  |x 1864-8126 
505 0 |a 1 Introduction -- 2 Secondary Metabolites of Cyanobacteria and Drug Development -- 3 Glycoconjugates of Cyanobacteria and Potential Drug Development from them -- 4 Anticancer Drug Development from Cyanobacteria -- 5 Issues and Challenges of Drug Development from Cyanobacteria. 
520 |a This volume presents recent developments in the novel drug development and potential of extremophilic cyanobacteria. It discusses how these tiny organism originated, produce oxygen that leads to evolution of life on the earth, how their survival strategies in extreme climatic conditions lead to diverse metabolic pathways, and the opportunity to use them to develop novel drugs. The book is comprised of five chapters, starting with the origin of cyanobacteria, their survival strategies under extreme conditions, and their capabilities to change metabolic activities.The second chapter explores the different metabolic pathways found in cyanobacteria and examines advances in this field and recent techniques like MALDI-TOF imaging and metagenomics tools as well as in silico techniques for rapid screening of secondary metabolites. Further chapters cover the glycomics of cyanobacteria, anticancer drug development, and some issues and challenges of using cyanobacteria to develop drugs. Extremophilic Cyanobacteria For Novel Drug Development provides insight into future perspectives in drug development and is a key resource for students, researchers and professionals in pharmacy, medicinal chemistry, pharmacognosy biotechnology, biology, and academics. 
650 0 |a Pharmaceutical chemistry. 
650 1 4 |a Pharmaceutics. 
700 1 |a Rath, Jnanendra.  |e author.  |4 aut  |4 http://id.loc.gov/vocabulary/relators/aut 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer Nature eBook 
776 0 8 |i Printed edition:  |z 9783319120102 
776 0 8 |i Printed edition:  |z 9783319120089 
830 0 |a SpringerBriefs in Pharmaceutical Science & Drug Development,  |x 1864-8126 
856 4 0 |u https://doi.uam.elogim.com/10.1007/978-3-319-12009-6  |z Texto Completo 
912 |a ZDB-2-SME 
912 |a ZDB-2-SXM 
950 |a Medicine (SpringerNature-11650) 
950 |a Medicine (R0) (SpringerNature-43714) 

Ejemplares similares